Login to Your Account

Other News To Note

Friday, February 15, 2013
• DARA BioSciences Inc., of Raleigh, N.C., was notified by Nasdaq that the company regained compliance with Rule 5550(a)(2), which requires a minimum bid price of $1 for continued listing.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription